Genovac LLC

Genovac is an expert biotechnology company that specialises in antibody discovery, offering innovative technologies and solutions for the development of therapeutic and diagnostic antibodies. With over 25 years of experience, Genovac delivers cutting-edge tools and platforms for rapid and precise antibody production, helping clients across the biopharma sector achieve success in complex target discovery.

Genovac is renowned for its pioneering approach to antibody discovery, combining advanced immunisation technologies, single B-cell screening platforms, and custom species options. Their expertise spans the full spectrum of antibody production, from cDNA synthesis to large-scale manufacturing. The company has successfully completed over 3,600 projects, delivering antibody hits for challenging targets such as ion channels and GPCRs.

Key Products and Services

• Antibody discovery and screening
• Single B-cell screening platforms
• Immunisation technologies
• Antibody production and characterisation
• Protein and plasmid production
• Custom antibody catalogues
• Target analysis services

Genovac’s ability to discover antibodies against difficult targets with speed and precision makes it a valuable partner in drug development. Their commitment to advancing science ensures continued leadership in the antibody discovery field.